Sheba R. David
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery 13
- Drug Solubulity and Delivery Systems 6
- Advanced Drug Delivery Systems 5
- Toxicology top 10%
- Dermatology top 10%
-
- Nanoparticle-Based Drug Delivery 3
-
- Natural Antidiabetic Agents Studies 4
-
- Pelvic floor disorders treatments 3
-
- Urinary Bladder and Prostate Research 3
-
- Nanoparticles: synthesis and applications 3
- Co-authors
- Rajan RajabalayaIhsan Nazurah ZulkipliNurolaini KifliAdi IdrisSrikumar ChakravarthiJestin ChellianSanjoy K. DasLin Naing
- Journals
- SHILAP Revista de lepidopterología (2 papers)Scientific Reports (1 paper)Molecules (1 paper)
In The Last Decade
Sheba R. David
41 papers receiving 702 citations
Peers
Comparison fields: 5 of 131
- Pharmaceutical Science 225
- Complementary and alternative medicine 72
- Toxicology 23
- Dermatology 54
- Biomaterials 74
Countries citing papers authored by Sheba R. David
This map shows the geographic impact of Sheba R. David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheba R. David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheba R. David more than expected).
Fields of papers citing papers by Sheba R. David
This network shows the impact of papers produced by Sheba R. David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheba R. David. The network helps show where Sheba R. David may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheba R. David, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 61 | |
| 3 | 2021 | 3 | |
| 4 | 2021 | 71 | |
| 5 | 2021 | 9 | |
| 6 | 2020 | 19 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 3 | |
| 9 | 2018 | 12 | |
| 10 | 2017 | 46 | |
| 11 | 2017 | 6 | |
| 12 | 2017 | 109 | |
| 13 | 2017 | 22 | |
| 14 | 2015 | 14 | |
| 15 | 2015 | 5 | |
| 16 | 2015 | 27 | |
| 17 | 2014 | 21 | |
| 18 | Formulation and in vitro evaluation of ethosomes as vesicular carrier for enhanced topical delivery of isotretinoin | 2013 | 20 |
| 19 | Development and In Vitro Evaluation of Matrix Type Transdermal Delivery of Ondansetron Hydrochloride | 2012 | 3 |
| 20 | Preparation and evaluation of transdermal drug delivery of ondansetron hydrochloride: effect of vegetable oils as permeation enhancer | 2012 | 5 |
About Sheba R. David
Sheba R. David is a scholar working on Pharmaceutical Science, Complementary and alternative medicine and Aquatic Science, having authored 44 papers that have together received 726 indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (13 papers), Drug Solubulity and Delivery Systems (6 papers), Advanced Drug Delivery Systems (5 papers), Natural Antidiabetic Agents Studies (4 papers), Pelvic floor disorders treatments (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Urinary Bladder and Prostate Research (3 papers) and Nanoparticles: synthesis and applications (3 papers). The work is most often cited by research in Pharmaceutical Science (225 citations), Complementary and alternative medicine (72 citations) and Toxicology (23 citations). Sheba R. David has collaborated with scholars based in Brunei, Malaysia and India. Frequent co-authors include Rajan Rajabalaya, Ihsan Nazurah Zulkipli, Nurolaini Kifli, Adi Idris, Srikumar Chakravarthi, Jestin Chellian, Sanjoy K. Das, Lin Naing, Gaurav Gupta and Hanif Abdul Rahman. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.